Takeda Found Guilty in Pay-for-Delay Scheme Over Amitiza
A federal jury in Boston ruled that Takeda Pharmaceutical (TAK) is guilty of conspiring to delay the release of a generic version of its constipation drug, Amitiza. The company was found to have engaged in a reverse payment arrangement.
Tickers: $TAK